Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Food and Drug Administration (FDA) is urging health care professionals to always recheck their dosing calculations prior to administering Arginine Hydrochloride Injections and to be aware that several unlabeled adverse events may be associated with the use of the drug, according to the Postmarket Reviews section of the Volume 2, Number 2 2, 2009 issue of its quarterly online newsletter, Drug Safety News (DSN).

Read the rest of this entry »